RA CAPITAL MANAGEMENT L.P. 13D/13G Filings for Bright Minds Biosciences Inc. (DRUG)

RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Bright Minds Biosciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-05-15
4:51 pm
Sale		 2025-03-31 13G Bright Minds Biosciences Inc.
DRUG		 RA CAPITAL MANAGEMENT L.P. 206,427
2.900%		 -254,402decrease
(-55.21%)		 Filing
2024-11-12
4:15 pm
Purchase		 2024-11-04 13G Bright Minds Biosciences Inc.
DRUG		 RA CAPITAL MANAGEMENT L.P. 460,829
6.600%		 460,829increase
(New Position)		 Filing